Hilleman Laboratories’ thermostability technology to help improve coverage of Routine Immunisation…
Quarter of the current birth cohort of 27 million babies in India unimmunised
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
Brazilian National Sanitary Surveillance Agency certifies Next Breath
Next Breath is now authorised to conduct Pharmaceutical Equivalence studies for Brazil
Johnson & Johnson announces new collaboration to enhance access to anti-TB compound
Will expand reach to more than 130 low and middle-income countries outside of US Johnson & Johnson announced that its…
US FDA approves Zykadia for late-stage lung cancer
Breakthrough therapy drug approved four months ahead of review completion goal date
Glenmark’s novel monoclonal antibody GBR 900 enters human trials
GBR 900 is a first in class monoclonal antibody for the treatment of chronic pain targeting TrkA, the receptor of NGF
“Full immunisation is the birthright of every child”
Disease is an event, but prevented disease is a non-event. National Immunisation Week (April 24 to 30) is the appropriate time to…
Mylan challenges FDA ruling on Celecoxib exclusivity
Believes that the FDA has seriously erred in its decision in this case Mylan Inc. (Nasdaq: MYL) announced that it has filed suit…
Bilcare receives National Intellectual Property Award 2014 by GoI
Developed path-breaking technology solution - nonClonableID technology with over 200 patent applications and 36 granted patents…
FDA approves first human papillomavirus test for primary cervical cancer screening
The cobas HPV test is manufactured by Roche Molecular Systems
Jubilant Life Sciences receives ANDA approval
Spironolactone is the generic version of Aldactone®(of GD Searle) Jubilant Life Sciences Ltd, an integrated Pharmaceuticals and…